Share this:
Published on: July 06, 2017 at 12:00PM
Condition: Thyroid Gland Undifferentiated (Anaplastic) Carcinoma
Interventions: Drug: Docetaxel; Drug: Doxorubicin Hydrochloride; Radiation: Intensity-Modulated Radiation Therapy; Other: Laboratory Biomarker Analysis; Biological: Pembrolizumab; Procedure: Therapeutic Conventional Surgery
Sponsors: Mayo Clinic; National Cancer Institute (NCI)
Not yet recruiting – verified July 2017
http://ift.tt/2uTfAkI
More Stories
‘My 401k Misses You’: Black Woman Pumped To Meet Donald Trump In Philadelphia – July 18, 2023 at 04:56PM
Energy Provider Warns of Impending ‘Crisis,’ ‘Blackout Conditions’ Driven By Biden Plans – July 18, 2023 at 04:20PM
Dog starts barking at cows crossing a bridge, so the cows stop to have a look. – July 17, 2023 at 02:27PM